报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 71.83% | -18.46% | -1.83% | 28/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 73.17% | -18.92% | 0.16% | 26/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 73.05% | -20.25% | -14.68% | 24/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 85.63% | -4.37% | -2.8% | 12/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 88.09% | -1.65% | -2.39% | 11/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 90.25% | 1.17% | -1.48% | 8/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 91.61% | 2.12% | 2.31% | 5/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 89.54% | 4.38% | -0.04% | 6/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 89.57% | 4.02% | 0.42% | 7/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 89.2% | 4.68% | -0.56% | 10/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 89.7% | 6.3% | 4.57% | 10/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 85.78% | 5.61% | -0.38% | 20/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 86.11% | 7.26% | 1.05% | 21/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 85.22% | 8.27% | 0.98% | 21/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2021-03-31 | 84.39% | 17.85% | 3.9% | 17/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
2020-12-31 | 81.22% | 12.73% | 1.17% | 26/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
2020-09-30 | 80.28% | 2% | 2.01% | 21/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
2020-06-30 | 78.71% | 10.33% | 9.92% | 31/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
2020-03-31 | 71.6% | 2% | -0.62% | 20/54 | 70.26% | 我武生物 | 95.6% | 行业排名> |
2019-12-31 | 72.05% | -0.78% | -0.78% | 30/54 | 72.44% | 我武生物 | 96.43% | 行业排名> |
2018-12-31 | 72.62% | 3.17% | 1.8% | 25/54 | 71.54% | 我武生物 | 96.51% | 行业排名> |
2018-06-30 | 71.33% | 2% | 1.35% | 15/54 | 67.2% | 我武生物 | 96.46% | 行业排名> |
2017-12-31 | 70.39% | -3.22% | -3.22% | 22/54 | -887.82% | 我武生物 | 96.44% | 行业排名> |
2016-12-31 | 72.73% | -2.15% | -2.15% | 15/54 | 68.41% | 康辰药业 | 95.1% | 行业排名> |
2015-12-31 | 74.33% | -2.43% | -2.43% | 11/54 | 65.23% | 康辰药业 | 94.98% | 行业排名> |